AUG 21, 2021 7:27 PM PDT

The Molecular Gate That Enables SARS-CoV-2 to Infect Cells

WRITTEN BY: Carmen Leitch

Researchers investigating how the SARS-CoV-2 virus gets into cells to cause COVID-19 learned early on in the pandemic that the spike protein of the virus binds to receptors called ACE2, which can be found on human cells in the nose. Scientists have also been learning more about the viral spike protein, like how it is structured, and what sugar residues, which are in a chemical group known as glycans, stick to the spike.

Simulations of glycan N343 (magenta) as a molecular crowbar that pries open the SARS-CoV-2 spike's RBD (cyan). / Credit: Terra Sztain, Surl-Hee Ahn, Lorenzo Casalino (Amaro Lab, UCSD).

Glycans have a variety of biological roles, but scientists have now found that when it comes to SARS-CoV-2, they act like 'gates' on the spike protein that open up and give SARS-CoV-2 entry into cells. This work has been reported in Nature Chemistry.

“We essentially figured out how the spike actually opens and infects,” said senior study author Rommie Amaro, a professor of chemistry and biochemistry at the University of California San Diego. “We’ve unlocked an important secret of the spike in how it infects cells. Without this gate the virus basically is rendered incapable of infection.”

Other researchers have been trying to find ways to use these glycan residues to prevent COVID-19. Amara also suggested that this work can help scientists take advantage of the glycans in a therapeutic approach that might help prevent COVID-19; if the glycan gate can be 'locked,' it could potentially prevent infection.

Cropped from a colorized scanning electron micrograph of a cell (blue) infected with SARS-CoV-2 virus particles (pink), isolated from a patient sample. Image captured at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. / Credit: NIAID

The glycans coating the the spike protein seem to shield it from the immune system, which may see the sugars as harmless. Previous research on the glycans has shown the spike protein in one position. This research used supercomputers to simulate the dynamic movement of the glycans on the spike protein, illuminating a new aspect of the mechanism of infection.

“We were actually able to watch the opening and closing. That’s one of the really cool things these simulations give you: the ability to see really detailed movies. When you watch them you realize you’re seeing something that we otherwise would have ignored,” said Amaro. "It’s only because we captured the movie of the whole process that you actually see it doing its thing.”

The supercomputers at UC San Diego and the Texas Advanced Computing Center (TACC) at the University of Texas (UT) Austin enabled the researchers to look at 300 different perspectives of the portion of the spike protein that attaches to the ACE2 receptor - the receptor binding domain (RBD). One glycan, called N343, pried the RBD into position to let it link to ACE2. The scientists compared this movement to a “molecular crowbar."

Without the glycan gate, the RBD cannot move into a conformation that will trigger the infection, noted Jason McLellan, an associate professor of molecular biosciences at UT Austin.

Sources: UC San Diego, Nature Chemistry

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
APR 29, 2021
Clinical & Molecular DX
We've Now Collected Over 1 Million Coronavirus Sequences
APR 29, 2021
We've Now Collected Over 1 Million Coronavirus Sequences
Over 1.2 million genome sequences collected from 172 countries have been uploaded to a data-sharing site over the course ...
MAY 10, 2021
Coronavirus
Researchers Create a Vaccine For Multiple SARS Viruses, Including COVID-19 & Variants
MAY 10, 2021
Researchers Create a Vaccine For Multiple SARS Viruses, Including COVID-19 & Variants
The pandemic virus SARS-CoV-2 has changed the world in devastating ways, taking hundreds of thousands of lives & new var ...
JUN 04, 2021
Drug Discovery & Development
Scientists Identify 90 Drugs that Could be Repurposed to Fight COVID-19
JUN 04, 2021
Scientists Identify 90 Drugs that Could be Repurposed to Fight COVID-19
Researchers from The Scripps Research Institute in California have identified 90 drugs that could be repurposed for trea ...
JUN 07, 2021
Clinical & Molecular DX
COVID Test Results in a Second?
JUN 07, 2021
COVID Test Results in a Second?
Scientists have developed a handheld diagnostic device, capable of detecting the presence of the SARS-CoV-2’s spik ...
AUG 10, 2021
Health & Medicine
When Grandma's optimism bias gets in the way of perceiving COVID-19 risks
AUG 10, 2021
When Grandma's optimism bias gets in the way of perceiving COVID-19 risks
Researchers used Socioemotional Selective Theory to generate personalized interventions to heighten perceived risk
OCT 03, 2021
Coronavirus
Merck's COVID-19 Drug Halves Risk of Death in Mild & Moderate Cases
OCT 03, 2021
Merck's COVID-19 Drug Halves Risk of Death in Mild & Moderate Cases
While Dr. Anthony Fauci of NIAID is already stressing that people should still get vaccinated to help reduce COVID-19 in ...
Loading Comments...